UnitedHealth Group’s $3.3 billion acquisition of Amedisys faces a new hurdle as the U.S. Department of Justice sued to block ...

The government is citing concerns the deal would hinder access to home health and hospice services in the U.S.

(Reuters) - The U.S. Justice Department and three U.S. states filed a lawsuit on Tuesday to block UnitedHealth Group's $3.3 ...

The US Justice Department sued Tuesday to block UnitedHealth Group Inc.’s $3.3 billion ... also joined the complaint.

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Thursday, shares of Amedisys, Inc. (Symbol: AMED) entered into oversold territory, hitting an RSI reading of ...

Amedisys Inc is a provider of home health services to the chronic, co-morbid, aging American population. The company's operations include servicing patients through its segments home health, hospice ...

As of , had a $0.0 market capitalization, putting it in the percentile of companies in the industry. does not have a meaningful P/E due to negative earnings over the last 12 trailing months. ’s ...

In this article, we are going to take a look at where Texas Instruments Incorporated (NASDAQ:TXN) stands against other Jefferies’ top crowded semiconductor short positions’ stocks. With the ...

UnitedHealth (UNH) and Amedisys (NASDAQ:AMED) are expected to meet with Dept. of Justice officials in a final effort to persuade the agency to not file a lawsuit to block its proposed deal.

Panelists included U.S. Sen. Ted Cruz of Texas, U.S. Rep. Henry Cuellar, Laredo Mayor Dr. Victor Trevino and Nuevo Leon Governor Samuel Garcia. The panel was part of a series of events that began ...

UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers next week in a last-ditch effort to persuade the agency not to ...

UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers next week in a last-ditch effort to persuade the agency not to challenge ...